3 hours ago
1
Milestone Pharmaceuticals (NASDAQ:MIST) has launched a public offering to raise capital, that includes common shares, alongside both Series A and Series B warrants.
For certain, investors will have the option to purchase pre-funded warrants (which can later be converted into common shares) instead of
English (US) ·